tm logo
NIVMOA
Live/Pending
PUBLISHED FOR OPPOSITION

on 24 Oct 2023

Last Applicant/ Owned by

GSK Medicines Research Centre

Stevenage

GB

SG12NY

Serial Number

97717343 filed on 14th Dec 2022

Registration Number

N/A

Correspondent Address

Elizabeth K. Rucki

GSK

410 BLACKWELL STREET

LEGAL BRAND PROTECTION

DURHAM,NC 27701

Filing Basis

No Filing Basis

Disclaimer

NO DATA

NIVMOA

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatRead More

Classification Information


Class [005]
Pharmaceutical Products


Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Mark Details


Serial Number

No 97717343

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 84214324

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
24th Oct 2023PUBLISHED FOR OPPOSITION
24th Oct 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04th Oct 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18th Sep 2023ASSIGNED TO EXAMINER
18th Sep 2023APPROVED FOR PUB - PRINCIPAL REGISTER
12th Jul 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
12th Jul 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12th Jul 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
03rd Mar 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
02th Mar 2023ASSIGNED TO LIE